Regulation of protein kinase C by cyclic adenosine 3':5'-monophosphate and a tumor promoter in skeletal myoblasts

• Published in: The Journal of biological chemistry 1987-08, Vol.262 (22), p.10497-10501
• Main Authors: Narindrasorasak, S, Brickenden, A, Ball, E, Sanwal, B D
• Format: Article
• Language: English
• Subjects: Analytical, structural and metabolic biochemistry; Animals; Avian Sarcoma Viruses; Biological and medical sciences; Bucladesine - pharmacology; Cell Line; Cell Membrane - enzymology; Cell Transformation, Viral; Colforsin - pharmacology; Cyclic AMP - pharmacology; Cyclic AMP - physiology; Cytosol - enzymology; Enzymes and enzyme inhibitors; Fundamental and applied biological sciences. Psychology; Isoproterenol - pharmacology; Muscles - drug effects; Muscles - enzymology; Protein Kinase C - antagonists & inhibitors; Protein Kinase C - metabolism; Protein Kinases - metabolism; Rats; Tetradecanoylphorbol Acetate - pharmacology; Transferases
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1016/S0021-9258(18)60988-3

The specific activity of protein kinase C in rat skeletal myoblasts decreased when they were exposed for very short periods to isoproterenol, forskolin, dibutyryl cyclic AMP (Bt2cAMP), or the phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA). In the presence of Bt2cAMP or forskolin only the cytosolic but not the membrane-bound kinase activity was found to decrease. Treatment with TPA, however, led to a decrease in the activity of the enzyme both in the cytosolic as well as the membrane fractions. The effects observed in vivo could be duplicated in crude extracts of myoblasts incubated with cAMP analogues or TPA. In the presence of ATP, protein kinase C activity decreased considerably in crude cytosolic fractions treated with the cAMP analogues, but a requirement for ATP was not evident for the decrease in activity brought about by TPA. For the cAMP analogues the decrease in protein kinase C was also prevented by incubation of the extracts with an inhibitor of cAMP-dependent protein kinase. The regulation of protein kinase C by Bt2cAMP (but not by TPA) was altered in Rous sarcoma virus-transformed myoblasts. It is considered likely that a component affected by cAMP (probably a substrate for cAMP-dependent protein kinase) participates in the regulation of protein kinase C activity, and it is altered in unknown ways in transformed myoblasts.